TrialContraception2012

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.

Linda Hovanessian-Larsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.